Long-term response to recombinant human growth hormone therapy in Indian children with growth hormone deficiency
Background: Growth hormone deficiency (GHD) remains the most common indication for use of recombinant human growth hormone (rhGH) therapy in clinical practice. However, there is a paucity of studies focusing on long-term response to rhGH therapy in the Indian context. Aim: To determine the response...
Main Authors: | Monita Gahlot, Alpesh Goyal, Arun K C. Singh, Viveka P Jyotsna, Nandita Gupta, Rajesh Khadgawat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2019;volume=23;issue=4;spage=446;epage=451;aulast=Gahlot |
Similar Items
-
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015-12-01) -
Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency
by: Shuang Liang, et al.
Published: (2018-04-01) -
The Effects of gonadotropin-releasing hormone analog and a combination of gonadotropin-releasing hormone analog and recombinant human growth hormone on adult height in girls with early puberty
by: Ghodsieh Hajzadeh, et al.
Published: (2019-01-01) -
Can growth hormone treatment improve growth in children with severe growth failure due to anorexia nervosa? A preliminary pilot study
by: Juliane Léger, et al.
Published: (2017-11-01) -
Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis
by: Ping Li, et al.
Published: (2018-04-01)